Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 1, 2010, Pages 131-139

  Kårehed, Karin ^a   Wikström, Anna Karin ^a   Olsson, Anna Karin ^b   Larsson, Anders ^a   Olovsson, Matts ^a   Åkerud, Helena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; Coagulation; Fibrinogen; Histidine rich glycoprotein; Preeclampsia

Indexed keywords

FIBRINOGEN; HISTIDINE RICH PROTEINS; HISTIDINE-RICH PROTEINS; PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD; BLOOD CLOTTING; ENDOTHELIUM CELL; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; TISSUE DISTRIBUTION;

ADULT; BLOOD COAGULATION; ENDOTHELIAL CELLS; FEMALE; FIBRINOGEN; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROTEINS; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 74049149242     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016340903295618     Document Type: Article

References (33)

1. Baumwell S, Karumanchi SA Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract. 2007; 106:c72-81.
2. Lam C, Lim KH, Karumanchi SA Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension. 2005; 46:1077-85.
3. Wang Y, Lewis DF, Alexander J.S., Granger DN Endothelial barrierfunction in preeclampsia. Front Bio Sci. 2007; 12: 2412-24.
4. Heilmann L, Rath W, Pollow K. Hemostatic abnormalities in patients with severe preeclampsia. Clin Appl Thromb Hemost. 2007; 13:285-91.
5. Wickstrom K, Edelstam G, Lowbeer C.H., Hansson LO, Siegbahn A. Reference intervals for plasma levels of fibronec-tin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest. 2004; 64:31-40.
6. Konijnenberg A, Stokkers EW, van der Post JA, Schaap MC, Boer K, Bleker OP, et al. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol. 1997; 176:461-9.
7. Holthe MR, Staff AC, Berge L.N., Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol. 2004; 190:1128-34.
8. Williams VK, Griffiths AB, Carbone S, Hague WM Fibrin-ogen concentration and factor VIII activity in women with preeclampsia. Hypertens Pregnancy. 2007; 26:415-21.
9. Manten GT, Sikkema JM, Franx A, Hameeteman T.M., Visser GH, deGroot PG, et al Increased high molecular weight fibrinogen in pre-eclampsia. Thromb Res. 2003; 111:143-7.
10. Sahni A, Khorana AA, Baggs R.B., Peng H., Francis CW FGF-2 binding to fibrin(ogen) is required for augmented angio-genesis. Blood. 2006; 107:126-31.
11. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005; 3:1894-904.
12. Leung LL. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest. 1986; 77:1305-11.
13. Saigo K, Yoshida A, Ryo R., Yamaguchi N, Leung LL His-tidine-rich glycoprotein as a negative acute phase reactant. Am J Hematol. 1990; 34:149-50.
14. Jespersen J. Monitoring plasma antithrombin-III levels during infusion of antithrombin-III concentrate. Thromb Haemost. 1984; 52:214.
15. Tsuchida-Straeten N., Ensslen S, Schafer C., Woltje M, Denecke B, Moser M., et al Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG). J Thromb Haemost. 2005; 3:865-72.
16. Dixelius J, Olsson AK, Thulin A, Lee C., Johansson I, Claes-son-Welsh L. Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycopro-tein. Cancer Res. 2006; 66:2089-97.
17. Lee C, Dixelius J, Thulin A, Kawamura H, Claesson-Welsh L, Olsson AK. Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions. Exp Cell Res. 2006; 312:2547-56.
18. Halbmayer WM, Hopmeier P, Feichtinger C., Rubi K, Fischer M. Histidine-rich glycoprotein (HRG) in uncomplicated pregnancy and mild and moderate preeclampsia. Thromb Haemost. 1992; 67:585-6.
19. von Dadelszen P., Magee LA, Roberts JM Subclassification of preeclampsia. Hypertens Pregnancy. 2003; 22:143-8.
20. Egbor M, Ansari T, Morris N., Green CJ, Sibbons PD Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG. 2006; 113:580-9.
21. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008; 51:970-5.
22. Wikstrom AK, Larsson A, Eriksson U.J., Nash P., NordenLindeberg S, Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and lateonset preeclampsia. Obstet Gynecol. 2007; 109:1368-74.
23. Levine RJ, Maynard SE, Qian C, Lim K.H., England LJ, Yu KF, et al Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350:672-83.
24. Maynard S, Epstein FH, Karumanchi SA Preeclampsia and angiogenic imbalance. Annu Rev Med. 2008; 59:61-78.
25. Kanfer A, Bruch JF, Nguyen G, He C.J., Delarue F., Flahault A, et al Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclamp-sia. Lab Invest. 1996; 74:253-8.
26. Crispi F, Llurba E, Dominguez C., Martin-Gallan P, Cabero L, Gratacos E. Predictive value of angiogenic factors and uterine artery Doppler for early-versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008; 31:303-9.
27. Ustun Y, Engin-Ustun Y, Kamaci M. Association of fibrin-ogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2005; 121:154-8.
28. Jones AL, Hulett MD, Parish CR Histidine-rich glycoprotein: a novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol. 2005; 83:106-18.
29. Vanwildemeersch M, Olsson AK, Gottfridsson E, Claesson-Welsh L, Lindahl U., Spillmann D. The anti-angiogenic His/ Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent manner. J Biol Chem. 2006; 281:10298-304.
30. Leung LL, Harpel PC, Nachman R.L., Rabellino EM Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood. 1983; 62:1016-21.
31. Janes SL, Goodall AH Flow cytometric detectionofcirculating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci (Lond). 1994; 86:731-9.
32. Raijmakers MT, Peters WH, Steegers E.A., Poston L. NAD(P) H oxidase associated superoxide production in human placenta from normotensive and pre-eclamptic women. Placenta. 2004; 25(Suppl A):S85-9.
33. Bremme K, Ostlund E, Almqvist I., Heinonen K, Blomback M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol. 1992; 80:132-7.